GENERAL CHARACTERISTICS
Muscle relaxants, centrally acting agents. ATC Code М03В Х04.
Indications to Use:
Symptomatic treatment of muscular spasm in adults after a stroke.
Natural & Alternative Remedies
-
$23 -
GENERAL CHARACTERISTICS Urologicals. ATC Code G04В Х. Indications to Use: For complex treatment of inflammatory diseases of the urinary tract. Prophylaxis of the formation of urinary stones, including after their removal.$21 -
GENERAL CHARACTERISTICS Drugs for peptic ulcer and gastro-oesophageal reflux disease. Famotidine. ATC Code A02B A03. Indications to Use: • Benign gastric ulcer. • Peptic ulcer disease (treatment and prevention of relapses). • Hyper-secretory conditions, such as Zollinger-Ellison syndrome. • Treatment of gastroesophageal reflux disease (rreflux esophagitis). • Prevention of the development of symptoms and erosion or ulceration associated with gastroesophageal reflux disease.$11 -
GENERAL CHARACTERISTICS Antithrombotic agents. Vitamin K antagonists. ATC Code В01А А02. Indications to Use: Prevention and treatment of thrombosis (especially deep veins of the lower extremities), thromboembolic complications (pulmonary embolism, embolic strokes, myocardial infarction) and thrombus formation in the postoperative period in patients with mechanical prostheses of the heart valves.$11 -
GENERAL CHARACTERISTICS Selective calcium channel blockers with mainly vascular effects. ATC Code C08C A05. Indications to Use: Arterial hypertension; ischemic heart disease: chronic stable angina, vasospastic angina (Prinzmetal’s angina).$11 -
GENERAL CHARACTERISTICS Antianemic preparations. Iron, parenteral preparations. ATC Code В03А С. Indications to Use: Treatment of iron deficiency states with ineffectiveness or inability to treat with iron preparations for oral administration.$30 -
GENERAL CHARACTERISTICS Urologicals. Urinary concrement solvents. ATC Code G04B C. Indications to Use: Treatment and prevention of urolithiasis (presence in the kidney and ureter of primary and recurrent stones of varying size and localization); complications caused by the passage of fragments of stones after shock wave lithotripsy; renal colic; prevention of urinary calculus formation after their immediate removal and/or self-release; as part fo complex maintenance therapy of chronic pyelonephritis, chronic inflammatory diseases of the lower urinary tract (cystitis, urethritis) and chronic prostatitis.$15 -
GENERAL CHARACTERISTICS Urologicals. Urinary concrement solvents. ATC Code G04B C. Indications to Use: Treatment and prevention of urolithiasis (presence in the kidney and ureter of primary and recurrent stones of varying size and localization); complications caused by the passage of fragments of stones after shock wave lithotripsy; renal colic; prevention of urinary calculus formation after their immediate removal and/or self-release; as part fo complex maintenance therapy of chronic pyelonephritis, chronic inflammatory diseases of the lower urinary tract (cystitis, urethritis) and chronic prostatitis.$20 -
GENERAL CHARACTERISTICS Liver therapy. ATC Code A05А Х. Indications to Use: Chronic cholecystitis, chronic hepatitis, biliary dyskinesia.$20 -
GENERAL CHARACTERISTICS Liver therapy. ATC Code A05А Х. Indications to Use: Symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Treatment of acute pain in adult patients. Treatment of primary dysmenorrhea.$11 -
GENERAL CHARACTERISTICS Liver therapy. ATC Code A05А Х. Indications to Use: Symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Treatment of acute pain in adult patients. Treatment of primary dysmenorrhea.$16 -
GENERAL CHARACTERISTICS Psycholeptics. Hypnotics and sedatives. ATC Code N05С М. Indications to Use: Light forms of neurasthenia and neuroses accompanied by increased excitability, anxiety, fear and tension, irritability, depression, fatigue, cardiovascular neuroses with cardialgia and arterial hypertension, mild forms of sleep disturbance due to nervous and/or mental overwork, constant psychoemotional stress (“manager syndrome”), a decrease in memory and concentration, climacteric syndrome.$12 -
GENERAL CHARACTERISTICS Psycholeptics. Hypnotics and sedatives. ATC Code N05С М. Indications to Use: Light forms of neurasthenia and neuroses accompanied by increased excitability, anxiety, fear and tension, irritability, depression, fatigue, cardiovascular neuroses with cardialgia and arterial hypertension, mild forms of sleep disturbance due to nervous and/or mental overwork, constant psychoemotional stress (“manager syndrome”), a decrease in memory and concentration, climacteric syndrome.$11 -
GENERAL CHARACTERISTICS Antimycotics for systemic use. Triazole derivatives. ATC Code J02А С01. Indications to Use: Treatment of such diseases in adults as: – cryptococcal meningitis; – coccidioidomycosis; – invasive candidiasis; – candidiasis of the mucous membranes, including candidiasis of the oropharynx and candidiasis of the esophagus candidum, chronic candidiasis of the skin and mucous membranes; – chronic atrophic candidiasis (candidiasis caused by the use of dentures) with inefficiency of local dental hygiene means; – vaginal candidiasis, acute or recurrent, when local therapy is inappropriate; – Balanitis Candida, when local therapy is inappropriate; – dermatomycosis, including mycosis of feet, mycosis of smooth skin, inguinal dermatomycosis; multicolored lichen and candidal skin infections, when systemic therapy is inappropriate; – dermatophytic onychomycosis, when the use of other medicines is inappropriate. Prevention of such diseases in adults as: – relapse of cryptococcal meningitis in patients with a high risk of its development; – relapse of candidiasis of the oropharynx or esophagus in HIV-infected patients with a high risk of its development; – decrease in the frequency of recurrences of vaginal candidiasis (4 or more cases per year); – prophylaxis of candidiasis infections in patients with prolonged neutropenia (for example, patients with malignant blood diseases who receive chemotherapy or patients in the transplantation of hematopoietic stem cells). Children. The drug can be used in the form of capsules in this category of patients, when children are able to safely swallow the capsule, usually at the age of 5 years. The drug is used in children for the treatment of candidiasis of the mucous membranes (candidiasis of the oropharynx, candidosis of the esophagus), invasive candidiasis, cryptococcal meningitis and for the prevention of candidal infections in patients with reduced immunity. The drug can be used as maintenance therapy to prevent the recurrence of cryptococcal meningitis in children at high risk of its development. Therapy can begin before the results of culture and other laboratory studies; after receiving the results, antibiotic therapy should be adjusted accordingly.$12 -
Fluconazole-Zdorovye capsules 150 mg blister 3 pcs Флуконазол-Здоровье капсулы по 150 мг блистер 3штGENERAL CHARACTERISTICS Antimycotics for systemic use. Triazole derivatives. ATC Code J02А С01. Indications to Use: Treatment of such diseases in adults as: – cryptococcal meningitis; – coccidioidomycosis; – invasive candidiasis; – candidiasis of the mucous membranes, including candidiasis of the oropharynx and candidiasis of the esophagus candidum, chronic candidiasis of the skin and mucous membranes; – chronic atrophic candidiasis (candidiasis caused by the use of dentures) with inefficiency of local dental hygiene means; – vaginal candidiasis, acute or recurrent, when local therapy is inappropriate; – Balanitis Candida, when local therapy is inappropriate; – dermatomycosis, including mycosis of feet, mycosis of smooth skin, inguinal dermatomycosis; multicolored lichen and candidal skin infections, when systemic therapy is inappropriate; – dermatophytic onychomycosis, when the use of other medicines is inappropriate. Prevention of such diseases in adults as: – relapse of cryptococcal meningitis in patients with a high risk of its development; – relapse of candidiasis of the oropharynx or esophagus in HIV-infected patients with a high risk of its development; – decrease in the frequency of recurrences of vaginal candidiasis (4 or more cases per year); – prophylaxis of candidiasis infections in patients with prolonged neutropenia (for example, patients with malignant blood diseases who receive chemotherapy or patients in the transplantation of hematopoietic stem cells). Children. The drug can be used in the form of capsules in this category of patients, when children are able to safely swallow the capsule, usually at the age of 5 years. The drug is used in children for the treatment of candidiasis of the mucous membranes (candidiasis of the oropharynx, candidosis of the esophagus), invasive candidiasis, cryptococcal meningitis and for the prevention of candidal infections in patients with reduced immunity. The drug can be used as maintenance therapy to prevent the recurrence of cryptococcal meningitis in children at high risk of its development. Therapy can begin before the results of culture and other laboratory studies; after receiving the results, antibiotic therapy should be adjusted accordingly.$11 -
GENERAL CHARACTERISTICS Antimycotics for systemic use. Triazole derivatives. ATC Code J02А С01. Indications to Use: Treatment of such diseases in adults as: – cryptococcal meningitis; – coccidioidomycosis; – invasive candidiasis; – candidiasis of the mucous membranes, including candidiasis of the oropharynx and candidiasis of the esophagus candidum, chronic candidiasis of the skin and mucous membranes; – chronic atrophic candidiasis (candidiasis caused by the use of dentures) with inefficiency of local dental hygiene means; – vaginal candidiasis, acute or recurrent, when local therapy is inappropriate; – Balanitis Candida, when local therapy is inappropriate; – dermatomycosis, including mycosis of feet, mycosis of smooth skin, inguinal dermatomycosis; multicolored lichen and candidal skin infections, when systemic therapy is inappropriate; – dermatophytic onychomycosis, when the use of other medicines is inappropriate. Prevention of such diseases in adults as: – relapse of cryptococcal meningitis in patients with a high risk of its development; – relapse of candidiasis of the oropharynx or esophagus in HIV-infected patients with a high risk of its development; – decrease in the frequency of recurrences of vaginal candidiasis (4 or more cases per year); – prophylaxis of candidiasis infections in patients with prolonged neutropenia (for example, patients with malignant blood diseases who receive chemotherapy or patients in the transplantation of hematopoietic stem cells). Children. The drug can be used in the form of capsules in this category of patients, when children are able to safely swallow the capsule, usually at the age of 5 years. The drug is used in children for the treatment of candidiasis of the mucous membranes (candidiasis of the oropharynx, candidosis of the esophagus), invasive candidiasis, cryptococcal meningitis and for the prevention of candidal infections in patients with reduced immunity. The drug can be used as maintenance therapy to prevent the recurrence of cryptococcal meningitis in children at high risk of its development. Therapy can begin before the results of culture and other laboratory studies; after receiving the results, antibiotic therapy should be adjusted accordingly.$11 -
GENERAL CHARACTERISTICS Psychostimulants and nootropics. ATC Code N06B Х Indications to Use: • Chronic and latent insufficiency of cerebral circulation in atherosclerosis and arterial hypertension; angiodistonic ischemic stroke of the brain and the condition after a stroke of the brain. • Post-traumatic encephalasthenia. • Encephalopathy of various origins. • Psycho-organic syndrome with a predominance of memory impairment and other cognitive functions or disturbances in the emotional-volitional sphere. • labyrinthopathy – dizziness, tinnitus, nausea, vomiting, nystagmus. • Ménière syndrome. • Prevention of kinetosis.$22 -
DOSAGE FORM Cream. Main physical and chemical properties : white opaque cream. COMPOUND active ingredient : 1 g of cream contains azelaic acid in terms of 100% dry matter 200 mg; Excipients : benzoic acid (E 210), glycerol monostearate 40-55, macrogol stearate, "CUTINA CBS", octyldodecanol, propylene glycol, glycerin, purified water. PHARMACOTHERAPEUTIC GROUP Topical acne treatments. ATX code D10A X03. INDICATIONS Treatment of acne (common acne), characterized by the presence of comedones, papules, pustules and small nodules.$45 -
Dosage form Syrup. Active ingredient 5 ml of syrup contains althea root dry extract (extractant water) in terms of 20,0% content of polysaccharides – 7.5 mg. Indications Cough in acute and chronic respiratory diseases: bronchitis, laryngitis, tracheitis, bronchial asthma, whooping cough.$18 -
DOSAGE FORM Chewable tablets. Main physicochemical properties : tablets of grayish-brown color with inclusions, round shape, with a flat surface, a score and a bevel. COMPOSITION active ingredient: 1 tablet contains marshmallow herb (Althaea officinalis L.) dry extract 1:40 (extractant - drinking water) - 100 mg; excipients: light magnesium carbonate, aspartame (E 951), tartaric acid, povidone, sucrose (sucrose), calcium stearate, colloidal anhydrous silicon dioxide, flavoring (orange). PHARMACOTHERAPEUTIC GROUP Expectorants. ATX code R05C A05. INDICATIONS FOR USE Cough in acute and chronic respiratory diseases accompanied by the formation of thick and viscous bronchial secretions and/or impaired expectoration: bronchitis, pneumonia, bronchiectasis, bronchial asthma.$12 -
Dosage form Tablets №20. Active ingredient 1 tablet contains ambroxol hydrochloride, calculated on 100 % basis – 30 mg. Indications Secretolytic therapy in acute and chronic diseases associated with disorders of bronchial secretions and loosening mucus advancement.$20 -
Dosage form Nail polish for medical use. Active ingredient amorolfine hydrochloride equivalent to amorolfine 50 mg. Indications Fungal lesions caused by dermatomycete, yeast fungus and mold, without affecting the nail base. Treatment of uncomplicated distal and lateral onychomycosis caused by dermatomycete, yeast fungus and mold fungus, delimited by two nails. Prevention of fungal nail infections.$45 -
DOSAGE FORM Tablets. ACTIVE INGREDIENT 1 tablet contains acetylsalicylic acid in terms of 100% of the substance – 500 mg. INDICATIONS Symptomatic treatment of headache, toothache, sore throat caused by cold; fever; algodysmenorrhea; pain in muscles and joints; back pain; moderate pain caused by arthritis. In case of cold or acute respiratory disease for symptomatic relief of pain and fever.$13 -
Dosage form Tablets №50. Active ingredient 1 tablet contains 40 mg of valerian extractum spissium, equivalent to dry substance. Indications Great nervous agitation, insomnia, in combined therapy of mild functional cardiovascular disturbances.$11 -
Dosage form Tablets №50. Active ingredient 1 tablet contains: valerian extractum spissium - 20 mg. Indications Great nervous agitation, insomnia, migraine, in combined therapy of mild functional cardiovascular and gastrointestinal disturbances.$11 -
Dosage form Tablets. Active ingredient 1 tablet contains bismuth nitrate basic, calculated on 282 mg of bismuth oxide – 350 mg, magnesium carbonate heavy, calculated on 168.5 mg of magnesium oxide – 400 mg, sodium hydrocarbonate – 200 mg, buckthorn bark powder – 25 mg, sweet flag root powder – 25 mg. Indications In the complex therapy of gastric ulcer and duodenal ulcer, functional dyspepsia, hyperacid gastritis.$11 -
DOSAGE FORM Film-coated tablets. Main physicochemical properties: film-coated tablets of white or almost white color, round shape, with a biconvex surface, odorless or with a slight odor of ammonia. COMPOSITION active ingredient : bismuth subcitrate; 1 tablet contains 320 mg of bismuth subcitrate, which is equivalent to 120 mg of bismuth oxide; excipients: corn starch, povidone, polacrilin potassium, magnesium stearate, coating mixture (polyethylene glycol, titanium dioxide (E 171), polyvinyl alcohol, talc). PHARMACOTHERAPEUTIC GROUP Drugs for the treatment of peptic ulcer and gastroesophageal reflux disease. Bismuth subcitrate ATX code A02B X05. INDICATIONS FOR USE Gastric and duodenal ulcers, chronic gastritis, including those caused by Helicobacter pylori (as part of anti-Helicobacter therapy regimens).$41 -
Dosage form Tablets №50. Active ingredient 1 tablet contains glycine recalculated to 100% substance 100 mg. Indications Functional and organic diseases of the nervous system (neurosis, neurosis states, vegetovascular dystonia, the effects neuroinfections, traumatic brain injury, perinatal and other forms of encephalopathy, including alcoholic genesis), accompanied by increased excitability, emotional instability, decreased mental capacity, sleep disorders. Ischemic stroke and cerebrovascular diseases. As an additional means in treatment of alcoholism.$15 -
DOSAGE FORM Solution for external application - fluid 50 ml. Active ingredient 1 vial contains 50 ml of dimethylsulfoxide. Indications Dimexid® is used for the treatment of inflammatory diseases of the musculoskeletal system (rheumatoid arthritis, Bechterew’s disease, deforming osteoarthritis, arthropathy, ligament sprain), contusions/bruises, traumatic infiltrates, inflammatory edemas, purulent wounds, abscesses, acute and chronic osteomyelitis, nodal fever, streptococcal impetigo. Dimexid® can be used in combination with nonsteroid anti-inflammatory drugs as combined therapy of deforming osteoarthrosis and rheumatoid arthritis, in combination with topical antimicrobial agents for the treatment of scleroderma, acne, erysipelatous inflammation, boils, eczema, trophic ulcers and other skin diseases, in combination with heparin – for the therapy of thrombophlebitis. Also used in skin-plastic surgery for preservation of skin allografts.$15 -
Dosage form Capsules №2. Active ingredient 1 capsule contains fluconazole, in terms of 100 % of the substance, 150 mg. Indications Vaginal candidiasis in patients who were previously diagnosed with (or appear sporadically) doctor.$12